Global Biodefense Market 2020-2024

バイオディフェンスの世界市場:脾脱疽、天然痘、ボツリヌス中毒症、その他

◆タイトル:Global Biodefense Market 2020-2024
◆商品コード:IRTNTR43768
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2020年5月
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートではバイオディフェンスの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(脾脱疽、天然痘、ボツリヌス中毒症、その他)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・バイオディフェンスの世界市場:用途別(脾脱疽、天然痘、ボツリヌス中毒症、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析

Global Biodefense Market 2020-2024

Technavio has been monitoring the biodefense market and it is poised to grow by $ 3.22 billion during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing threat of bioterrorism, rapid increase in government funding in R&D and recent outbreaks of infectious diseases. In addition, growing threat of bioterrorism is anticipated to boost the growth of the market as well.

The biodefense market analysis includes application segment and geographic landscapes
Technavio’s biodefense market is segmented as below:
By Application
• Anthrax
• Smallpox
• Botulism
• Others

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the government initiatives as one of the prime reasons driving the biodefense market growth during the next few years. Also, growing collaborations and M&A and increasing healthcare expenditure will lead to sizable demand in the market.
“Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our biodefense market covers the following areas:
• Biodefense market sizing
• Biodefense market forecast
• Biodefense market industry analysis”

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-biodefense-market-2020-2024-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Anthrax – Market size and forecast 2019-2024
o Smallpox – Market size and forecast 2019-2024
o Botulism – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Application
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Alexeter Technologies LLC
o Alnylam Pharmaceuticals Inc.
o Altimmune Inc.
o ANP Technologies Inc.
o Bavarian Nordic AS
o Cleveland BioLabs Inc.
o Elusys Therapeutics Inc.
o Emergent BioSolutions Inc.
o General Dynamics Corp.
o GlaxoSmithKline Plc
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Application – Market share 2019-2024 (%)
• 22: Comparison by Application
• 23: Anthrax – Market size and forecast 2019-2024 ($ million)
• 24: Anthrax – Year-over-year growth 2019-2024 (%)
• 25: Smallpox – Market size and forecast 2019-2024 ($ million)
• 26: Smallpox – Year-over-year growth 2019-2024 (%)
• 27: Botulism – Market size and forecast 2019-2024 ($ million)
• 28: Botulism – Year-over-year growth 2019-2024 (%)
• 29: Others – Market size and forecast 2019-2024 ($ million)
• 30: Others – Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share by geography 2019-2024 (%)
• 34: Geographic comparison
• 35: North America – Market size and forecast 2019-2024 ($ million)
• 36: North America – Year-over-year growth 2019-2024 (%)
• 37: Europe – Market size and forecast 2019-2024 ($ million)
• 38: Europe – Year-over-year growth 2019-2024 (%)
• 39: Asia – Market size and forecast 2019-2024 ($ million)
• 40: Asia – Year-over-year growth 2019-2024 (%)
• 41: ROW – Market size and forecast 2019-2024 ($ million)
• 42: ROW – Year-over-year growth 2019-2024 (%)
• 43: Key leading countries
• 44: Market opportunity by geography ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: Alexeter Technologies LLC – Overview
• 52: Alexeter Technologies LLC – Product and service
• 53: Alexeter Technologies LLC – Key offerings
• 54: Alexeter Technologies LLC – Key customers
• 55: Alexeter Technologies LLC – Segment focus
• 56: Alnylam Pharmaceuticals Inc. – Overview
• 57: Alnylam Pharmaceuticals Inc. – Product and service
• 58: Alnylam Pharmaceuticals Inc. – Key offerings
• 59: Alnylam Pharmaceuticals Inc. – Key customers
• 60: Alnylam Pharmaceuticals Inc. – Segment focus
• 61: Altimmune Inc. – Overview
• 62: Altimmune Inc. – Business segments
• 63: Altimmune Inc. – Key offerings
• 64: Altimmune Inc. – Key customers
• 65: Altimmune Inc. – Segment focus
• 66: ANP Technologies Inc. – Overview
• 67: ANP Technologies Inc. – Product and service
• 68: ANP Technologies Inc. – Key offerings
• 69: ANP Technologies Inc. – Key customers
• 70: ANP Technologies Inc. – Segment focus
• 71: Bavarian Nordic AS – Overview
• 72: Bavarian Nordic AS – Business segments
• 73: Bavarian Nordic AS – Key offerings
• 74: Bavarian Nordic AS – Key customers
• 75: Bavarian Nordic AS – Segment focus
• 76: Cleveland BioLabs Inc. – Overview
• 77: Cleveland BioLabs Inc. – Product and service
• 78: Cleveland BioLabs Inc. – Key offerings
• 79: Cleveland BioLabs Inc. – Key customers
• 80: Cleveland BioLabs Inc. – Segment focus
• 81: Elusys Therapeutics Inc. – Overview
• 82: Elusys Therapeutics Inc. – Product and service
• 83: Elusys Therapeutics Inc. – Key offerings
• 84: Elusys Therapeutics Inc. – Key customers
• 85: Elusys Therapeutics Inc. – Segment focus
• 86: Emergent BioSolutions Inc. – Overview
• 87: Emergent BioSolutions Inc. – Business segments
• 88: Emergent BioSolutions Inc. – Key offerings
• 89: Emergent BioSolutions Inc. – Key customers
• 90: Emergent BioSolutions Inc. – Segment focus
• 91: General Dynamics Corp. – Overview
• 92: General Dynamics Corp. – Business segments
• 93: General Dynamics Corp. – Key offerings
• 94: General Dynamics Corp. – Key customers
• 95: General Dynamics Corp. – Segment focus
• 96: GlaxoSmithKline Plc – Overview
• 97: GlaxoSmithKline Plc – Business segments
• 98: GlaxoSmithKline Plc – Key offerings
• 99: GlaxoSmithKline Plc – Key customers
• 100: GlaxoSmithKline Plc – Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations



【掲載企業】

Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., GlaxoSmithKline Plc

★調査レポート[バイオディフェンスの世界市場:脾脱疽、天然痘、ボツリヌス中毒症、その他] (Global Biodefense Market 2020-2024 / IRTNTR43768)販売に関する免責事項
[バイオディフェンスの世界市場:脾脱疽、天然痘、ボツリヌス中毒症、その他] (Global Biodefense Market 2020-2024 / IRTNTR43768)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆